YFY Biotech Management Company
About Us
Company Profile
Management Team
Capital Funds
Portfolio
News
Contact Us
繁體
English
News
SEARCH
Year
2024
2023
2022
2021
2020
2019
2018
2017
Aug 8, 2017
MVC obtains TFDA’s approval to initiate EV71 vaccine’s phase 3 CT
READ MORE
Aug 7, 2017
Enrollment of first patient in melanoma phase II clinical trial for Telomelysin® (OBP-301) in the US
READ MORE
Aug 7, 2017
Taiwan-ASEAN Drug Regulatory Forum Visits TLC
READ MORE
Aug 2, 2017
The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics cGMP Manufacturing Facilities for Production of TM
READ MORE
Jul 25, 2017
TLC to Receive Government Grant for Development of Ophthalmology Product Candidate TLC399
READ MORE
Jul 20, 2017
TLC Receives Orphan Drug Designation by US FDA of TLC178 for the Treatment of Soft Tissue Sarcoma
READ MORE
Jul 12, 2017
Mycenax receive NDA approval for TuNEX from TFDA
READ MORE
Jul 11, 2017
TLC Announces Issuance of Patents for Three Product Candidates
READ MORE
prev
1
2
3
4
5
next
YFY Biotech Management Company